SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Dynamics Regulatory News (ABDP)

Share Price Information for AB Dynamics (ABDP)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,046.00
Ask:
1,054.00
Spread: 8.00 (0.765%)
Market Cap: £241.72m
ABDP Live PriceLast checked at - London Stock Exchange

Intraday AB Dynamics Share Chart

Pre-close Trading Update

23 Sep 2025 07:00

RNS Number : 3241A
AB Dynamics PLC
23 September 2025
 

23 September 2025

AB Dynamics plc

Pre-close Trading Update

 

AB Dynamics plc ("AB Dynamics", the "Company" or the "Group"), the designer, manufacturer and supplier of advanced testing, simulation and measurement products and services to the global transport market, issues the following trading update in advance of the publication of its results for the year ended 31 August 2025 ("FY 2025").

 

Full year profitability slightly ahead of expectations

 

The Board expects full year revenue to exceed £114m. Following strong trading in the first half of the year with double digit revenue growth, the second half was impacted by short-term uncertainty created by macroeconomic and geopolitical challenges, such as US-led trade tariffs, which resulted in some delays to customer order placement. Encouragingly, underlying demand drivers remain strong and customer activity increased towards the end of the year.

 

As a result, the Group carries forward £32m (2024: £31m) of orders into FY 2026 providing good trading momentum into the first half of the year. As a global market leading supplier of critical technology products and services, with a broad international footprint, the Group has an inherently resilient profile leaving it well placed to manage effectively through any short-term market headwinds.

 

A primary focus of the Group's medium-term growth plan is to enhance operating margins and the Board expects the operating margin for FY 2025 to exceed 20%, representing an increase of at least 180bps over the prior year. This has been achieved through operational improvements and a richer mix of revenue, largely resulting from the timing of order intake and delivery.

 

The operational improvements implemented in recent years have contributed to building a strong platform to support further growth, and although the benefit of the revenue mix is not expected to be repeated in FY 2026, the Board is confident of achieving its medium-term sustainable target margin of greater than 20%.

 

As a result of this robust margin performance, full year adjusted operating profit for FY2025 is anticipated to be slightly ahead of current market expectations1.

 

Strong growth in Testing Products and Testing Services

 

Testing Products has performed strongly, with growth driven by customer demand for driving robots in North America and Asia Pacific.

 

The Testing Services business also saw continued growth, largely driven by the Group's US based operations with positive developments in the mileage accumulation and track testing markets.

 

In Simulation, a material order for a driving simulator was received later in the second half of the year than anticipated. The timing of order placement has delayed delivery from FY 2025 into FY 2026, thus revenue for Simulation is now expected to be lower than in the prior year.

 

Financial position and cash flow

 

The Group maintained its track record of strong operating cash conversion, with net cash at 31 August 2025 of £41.4m (2024: £28.6m), driven by continued effective working capital discipline.

 

Chief Executive Officer update

On 8 July 2025 the Group announced that James Routh had informed the Board of his intention to take up the Chief Executive position at Victrex plc. The process of appointing James's replacement, which includes internal and external candidates, is progressing to plan and the Board expects to be able to provide a further update no later than by the date of presenting the Group's FY 2025 full year results announcement.

 

Notice of Full Year results announcement

The Group expects to announce full year results on 11 November 2025.

 

1 The Company compiled analyst expectations is for a mean adjusted operating profit for the year ended 31 August 2025 of £22.3m.

 

Enquiries:

AB Dynamics plc

01225 860 200

Dr James Routh, Chief Executive Officer

Sarah Matthews-DeMers, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Joint Broker)

0207 418 8900

Mike Bell

Ed Allsopp

 

Stifel Nicolaus Europe Limited (Joint Broker)

0207 418 8900

Matthew Blawat

Orme Clarke

 

Teneo

0207 353 4200

James Macey White

Matt Low

 

The person responsible for arranging the release of this information is David Forbes, Company Secretary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKNAALSSEFA
Date   Source Headline
19th May 20267:00 amRNSGrant of SAYE Options and PDMR dealings
28th Apr 202612:47 pmRNSAIM Rule 17 Disclosure
27th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
14th Apr 20261:45 pmRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSHalf-year Report
12th Mar 20267:00 amRNSHalf Year Trading Update and Notice of Results
19th Feb 20267:00 amRNSAppointment of Interim Chief Financial Officer
15th Jan 20264:30 pmRNSResult of AGM
15th Jan 20267:00 amRNSAGM Trading Update
7th Jan 20267:00 amRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSContract award and confirmation of Board change
25th Nov 202512:46 pmRNSHolding(s) in Company
25th Nov 202512:46 pmRNSHolding(s) in Company
25th Nov 202512:46 pmRNSHolding(s) in Company
25th Nov 202512:46 pmRNSHolding(s) in Company
25th Nov 202512:45 pmRNSPDMR/PCA Shareholding
24th Nov 20252:15 pmRNSNotice of AGM and Posting of Annual Report
17th Nov 20257:00 amRNSShares Awards and Director/PDMR Dealings
14th Nov 20257:00 amRNSBlock listing Interim Review
11th Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results
21st Oct 20257:00 amRNSCEO Appointment
23rd Sep 20257:00 amRNSPre-close Trading Update
9th Jul 20252:46 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSBoard Change
26th Jun 20257:00 amRNSTrading Update and Capital Markets Day
18th Jun 20259:00 amRNSBlock Listing Six Monthly Return
9th Jun 20253:15 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSDirectorate Changes
23rd Apr 20257:00 amRNSHalf-year Report
25th Mar 20257:00 amRNSHalf Year Trading Update and Notice of Results
11th Mar 20254:30 pmRNSHolding(s) in Company
26th Feb 20253:15 pmRNSHolding(s) in Company
16th Jan 20253:45 pmRNSResult of AGM
16th Jan 20257:00 amRNSAGM Trading Update
13th Dec 20247:00 amRNSShares Awards and Director/PDMR Dealings
11th Dec 20242:15 pmRNSNotice of AGM and Posting of Annual Report
26th Nov 20247:00 amRNSFinal Results
21st Nov 20245:00 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSNotice of Results
1st Nov 20247:00 amRNSBlock Listing Six Monthly Return
18th Oct 20243:30 pmRNSHolding(s) in Company
27th Sep 20244:00 pmRNSHolding(s) in Company
27th Sep 20247:00 amRNSPDMR/ PCA Shareholding
26th Sep 20247:00 amRNSPre-close Trading Update and Acquisition
17th Jun 202411:00 amRNSBlock listing Interim Review
10th May 20249:30 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSTotal Voting Rights
23rd Apr 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.